Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs

JAMA Netw Open. 2022 Feb 1;5(2):e220035. doi: 10.1001/jamanetworkopen.2022.0035.

Abstract

This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Authorship*
  • Biomedical Research / statistics & numerical data*
  • Cardiovascular Agents*
  • Clinical Trials as Topic / statistics & numerical data*
  • Cross-Sectional Studies
  • Drug Approval
  • Female
  • Humans
  • Male
  • Sex Distribution*
  • United States / epidemiology
  • United States Food and Drug Administration
  • Women

Substances

  • Cardiovascular Agents